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Abstract The aim of this study was to investigate the
changes in the peripheral blood of newborns of hypertensive
mothers. The umbilical cord blood from newborns of 31
hypertensive mothers and 32 healthy mothers were examined.
In all subjects, complete blood count, peripheral blood smear,
reticulocyte count, vitamin B12, folate, ferritin levels and
hemoglobin electrophoresis were performed. The subjects
were followed up on for 1 year in terms of infections. RBC,
hemoglobin, reticulocyte count and normoblast count were
higher in the newborns of hypertensive mothers compared to
the control group, and total leukocytes, neutrophil, lympho-
cyte, monocyte, eosinophil, and thrombocyte counts were
lower. The number of neutropenic and thrombocytopenic
subjects in newborns of hypertensive mothers was higher
compared to the control group. On peripheral smears, dys-
plastic changes in neutrophils and erythrocytes were observed
with a higher rate in newborns of hypertensive mothers com-
pared to the control group. HbF levels were found to be higher
in newborns of hypertensive mothers compared to the control
group. During the follow-up period of 1 year, the number of
infections in newborns of hypertensive mothers was found to
be higher than the control group. Conclusion: Newborns of
hypertensive mothers should be carefully evaluated and mon-
itored in terms of hematologic abnormalities. Complete blood
counts and peripheral blood smears can be used as significant
parameters for early diagnosis of possible complications.
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Introduction
Hypertensive diseases of pregnancy are classified as pre-
eclampsia–eclampsia, chronic hypertension, preeclampsia–
eclampsia developed in the background of chronic hyperten-
sion, and transient hypertension [19]. The uteroplacental unit
is one of the organs which is affected by capillary damage in
hypertensive pregnant women. Early and long-term hyper-
tension may lead to uteroplacental failure, fetal distress,
intrauterine growth retardation (IUGR) and preterm delivery.
It was shown that the risk of polycythemia was higher in
babies of hypertensive mothers compared to the general
population and maternal hypertension constituted a signifi-
cant risk for polycythemia independent of fetal growth [12].
It has been reported that nucleated red blood cells increase
secondary to uteroplacental hypoperfusion in babies of pre-
eclamptic mothers [17]. In addition, it was shown that the
possibility of thrombocytopenia was higher in newborns of
preeclamptic mothers who had hypertension and especially
thrombocytopenia, compared to normotensive mothers [4,
16]. Preeclampsia has been reported to be a risk factor for
neonatal neutropenia and infections in premature newborns
[6]. Therefore, early detection and prophylactic treatment are
recommended in newborns at high risk.
Newborns of hypertensive mothers have a risk for poly-
cythemic, infectious, and bleeding complications. However,
there is no study comprehensively investigating the changes
in hematologic parameters in the newborns which may be
caused by hypertension in the mothers. In this study, the
changes in the hematologic parameters were investigated in
newborns of hypertensive mothers, including the morphol-
ogies of blood cells.
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Materials and methods
Thirty-one pregnant women with a diagnosis of hypertension
for at least 3 months and their newborns constituted the study
group, and 32 healthy pregnant women and their newborns
constituted the control group. Arterial blood pressure
≥140/90 mmHg was defined as hypertension. Women who
have hypertension with proteinuria and/or edema that happens
after 20th gestational week were defined as preeclamptic
pregnant women. Women who have hypertension without
the other signs of preeclampsia that happens during the preg-
nancy were defined as pregnant women with transient hyper-
tension. Women who had hypertension also before the preg-
nancy or whose blood pressure ≥140/90 mmHg before the
20th gestational week were defined as chronic hypertensive
pregnant women [19]. Newborns whose mothers used another
drug in addition to anti-hypertensive drugs, whose mothers
had another chronic disease, whose gestational age was <24-
weeks, who had chromosomal anomalies, congential meta-
bolic diseases, congenital malformations, premature rupture
of membranes, perinatal infections and hematologic or endo-
crine diseases were excluded from the study.
The demographic data of the mothers (age, chronic dis-
ease, drug usage, parity, blood group, gestational week,
interventional procedures during pregnancy, problems dur-
ing pregnancy, mode of delivery, administration of anesthe-
sia, delivery induction, presence of meconium, fetal decel-
eration and presence of a nuchal cord), birth weight of the
newborn, gender of the newborn, Apgar scores at the first
and fifth minutes and resuscitation status were recorded.
Before the investigations were initiated, the content of the
study was explained to the families and written informed
consent was obtained.
In all subjects, umbilical cord blood was obtained after
delivery and complete blood count, peripheral blood smear,
reticulocyte count, serum vitamin B12, folate, ferritin levels
and hemoglobin electrophoresis analyses were performed.
Complete blood count was performed by a hemocytometer
after routine daily calibration (Beckman Coulter PN
72377817, 2004 Fullerton, California, USA). Serum vitamin
B12 (reference range 200–835 pg/mL), folate (reference range
5-21 ng/mL) and ferritin levels (reference range 13–
150 ng/mL) were measured using a Modular Analytics E170
device with electrochemiluminescence immunologic test sys-
tem (Hitachi Automatic Analyzer 1679-01 Tokyo, Japan) and
hemoglobin electrophoresis was performed using a Sebia
Hydrasys device with a semi-automatic agaroze gel electropho-
resis system (Model 3187, 02/49, France).
In peripheral blood smears, neutrophils were examined in
terms of hypersegmentation, nuclear abnormalities (a nucle-
us with hook, lump, flag-like projections or microlobes and
pseudo Pelger–Huet anomalies), cytoplasmic abnormalities
(hypogranulation or agranulation and granule distribution
abnormalities), and membrane abnormalities (protrusion,
loss of integrity). A segmentation index was calculated
([number of neutrophils with ≥5 lobes/number of neutrophils
with 4 lobes]×100) and a value of >16.9 was considered to
be abnormal [2]. Smears with 2 % or more damaged nuclei
was considered a nuclear structural defect, smears with 2 %
or more hypogranulation was considered agranulation,
smears with granule distribution abnormalities were consid-
ered cytoplasmic granule defects and smears with loss of
membrane integrity were considered membrane abnormali-
ties. One hundred thrombocytes were examined to detect the
presence of giant thrombocytes (>20 % of thrombocytes
with a diameter of >4 μm and >3 % of thrombocytes with
a diameter >8 μm). The detected erythrocyte anomalies
(spherocytes, poikilocytosis, polychromasia, anisocytosis,
etc.) were also recorded.
Statistical analysis The data were analyzed and processed in
the computer using SPSS for Windows 11.0 Package pro-
gram. In descriptive statistics, numbers and percentages
were used for discontinuous variables, mean±standard
deviation and minimum and maximum values were used
for continuous variables. Chi-square (χ2) was used for
comparison of discontinuous variables. The differences
between groups were compared using T tests for the
ones with a normal distribution and Mann–Whitney tests
for the ones which had no normal distribution. Logistic
regression analysis was done to define the risk related to
independent variables. A p value of <0.05 was consid-
ered to be significant.
Results
Since no mother with eclampsia and acute hypertension
developed in the background of chronic hypertension
was present in the study group, hypertensive mothers
were examined in three groups (preeclampsia, chronic
hypertension, and transient hypertension induced by
pregnancy).
Demographic findings
During the study, 31 of 63 neonates with a gestational age
between 27 and 39 weeks born in our center were considered
the study group and 32 of 63 neonates were considered the
control group. The perinatal and neonatal properties of a total
of 63 subjects constituting the study group and the control
group are shown in Table 1.
There was no difference between the groups in terms
of maternal age, parity, gestational week, prematurity
state, mode of delivery, interventional procedures during
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pregnancy, meconium, nuchal cord, deceleration, neonatal
resuscitation, Apgar scores at the first and fifth minutes,
gender and neonatal mortality (p>0.05). The number of gen-
eral anesthesia in the study group and the number of spinal
anesthesia in the control group was found to be higher. There
was a significant difference between the two groups in terms
of anesthesia procedures (p=0.002). Birth weight in the study
group was significantly lower compared to the control group
(p=0.008). No labor induction was performed in the pregnant
women in either group. In the study group, one subject was
lost after delivery because of prematurity and sepsis at the age
of 3 days and there was no difference between the two groups
in terms of neonatal mortality (p=0.3). This subject was a
newborn born from a preeclamptic mother at the 27th gesta-
tional week with a birth weight of 820 g who had neutropenia
and thrombocytopenia.
The hypertensive group included 20 (64.5 %) preeclamptic
pregnant women, 8 (25.8 %) pregnant women with transient
hypertension induced by pregnancy and 3 (9.7 %) chronically
hypertensive pregnant women. Mild preeclampsia was present
in 14 (70 %) of the preeclamptic mothers and moderate pre-
eclampsia was present in 6 (30 %); 300 mg–3 g/day proteinuria
was found in 85 % of the preeclamptic mothers and 3–5 g/day
proteinuria was found in 15 %. Three mothers who were
hypertensive for more than 6 months were considered to be in
the chronic hypertension group. Twenty of 28 mothers with a
hypertension period of 3–6 months were preeclamptic mothers
and the diagnosis for preeclamptic mothers was made before
the 20th gestational week. Eight hypertensive mothers were
diagnosed as transient hypertension induced by pregnancy, and
hypertension started after the 20th gestational week and
returned to normal before the 6th week after delivery in these
mothers. Seven of the preeclamptic mothers, one of themothers
with transient hypertension induced by pregnancy, and all of
the mothers with chronic hypertension were using anti-
hypertensive drugs. Metoprolol was used by chronic hyper-
tensive pregnant women (three women) and nifedipine and
α methyl-dopa were used by the pregnant women belong-
ing to the other groups (eight women). No severe side
effects were observed with the aforementioned drugs.
When the subjects whose mothers used drugs were com-
pared with the subjects who did not use drugs, no signif-
icant difference was found in terms of birth weight
(1,781±788.3 vs. 2,172.3±679.7 g), Apgar score at the first
minute (7.7±2.45 vs. 7.8±1.4) and Apgar score at the fifth
minute (8.8±2.2 vs. 9.6±0.8) (p>0.05).
Table 1 Prenatal–neonatal
properties of the subjects
The values in italics demonstrate
that p values less than <0.05 and
consider to be statistically
significant
a Values are given as mean±SD
(standard deviation) (minimum–
maximum)
bValues are given as numbers (%)
Parameter Study group (n=31) Control group (n=32) p
Maternal age (years)a 28.83±4.56 (21–38) 29.81±4.77 (19–41) 0.41
Number of the pregnancyb
1 19 (61.3) 19 (59.4) 0.36
2 9 (29.0) 6 (18.8)
3 1 (3.2) 3 (9.4)
4 2 (6.5) 3 (9.4)
5 0 (0) 1 (3.1)
Paritya 1.54±0.85 (1–4) 1.78±1.15 (1–5) 0.36
Gestational age (weeks)a 34.19±2.78 (27–39) 35.00±2.75 (27–39) 0.25
Premature (≤37 weeks)b 25 (80.6) 22 (68.8)
Mature (>37 weeks)b 6 (19.4) 10 (31.2) 0.27
Mode of delivery (vaginal/Cesarean) 2/29 5/27 0.25
Anesthesia for deliveryb General 23 (74.2) 10 (31.3) 0.002
Spinal 6 (19.4) 17 (53.1) 0.002




Meconium 0/31 2/32 0.15
Nuchal cord 1/31 1/32 0.98
Deceleration 2/31 7/32 0.08
Neonatal resuscitation 6/31 3/32 0.25
Apgar score at the first minutea 7.77±1.76 (2–10) 8.40±0.94 (4–9) 0.08
Apgar score at the fifth minutea 9.32±1.42 (3–10) 9.81±0.47 (8–10) 0.07
Birth weight (grams)a 2046.12±727.35 (820–3,500) 2595.31±845.89
(1,000–4,400)
0.008
Gender (male/female) 14/17 11/21 0.39
Neonatal death 1/31 0/32 0.3
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Complete blood count findings
A hemoglobin value of <13.5 g/dl was considered anemia and
a venous hematocrit value of >65 % was considered polycy-
themia. A neutrophil count of <1,500/mm3 was considered
neutropenia, a lymphocyte count of <3,000/mm3 was consid-
ered lymphopenia and a thrombocyte count of <150,000/mm3
was considered thrombocytopenia.
Complete blood count parameters of both groups are
shown in Table 2 and the state of cytopenic subjects are
shown in Table 3.
(a) Erythrocyte indices
When the two groups were examined in terms of anemia, the
study group included one anemic subject, the control group
included three anemic subjects, and no significant difference
was found between the two groups in terms of anemia
(p=0.31). None of the groups included polycythemic sub-
jects. When the two groups were compared in terms of
erythrocyte indices, no significant difference was found be-
tween the two groups in terms of MCV, MCH, and MCHC
(p>0.05). RBC, hemoglobin, RDW, reticulocyte percentage,
and the number of normoblasts were significantly higher in
the study group compared to the controls (p<0.05).
(b) Leukocyte indices
Among leukocyte indices, total leukocyte, neutrophil, lym-
phocyte, monocyte and eosinophil counts were found to be
lower in the study group compared to the controls (p<0.05).
No difference was found between the two groups in terms of
basophil counts (p>0.05).
When the two groups were evaluated in terms of cytopenia,
18 neutropenic subjects (4 severely neutropenic, 6 moderately
neutropenic, 8 mildly neutropenic), 11 lymphopenic subjects,
and 4 neutropenic+lymphopenic (1 severely neutropenic, 3
mildly neutropenic) subjects were found in the study group. In
the control group, 2 neutropenic subjects and 6 lymphopenic
subjects were found. When the cytopenic subjects were ex-
amined, the total number of neutropenic subjects in the study
group was found to be higher compared to the control group
(p<0.001). Among neutropenic subjects, the numbers of
mildly, moderately and severely neutropenic subjects were
found to be higher in the study group (p<0.05). No difference
was found between the two groups in terms of the number of
lymphopenic subjects (p>0.05).
(c) Thrombocyte indices
MPVand PDW values were found to be significantly higher
in the study group (p<0.05). Thrombocyte counts in the
subjects in the study group were found to be lower compared
to the control group (p<0.001).
When the two groups were evaluated in terms of cytopenia,
ten thrombocytopenic subjects were found in the study group.
Neutropenia and/or lymphopenia were found in thrombocy-
topenic subjects. There was no subject with isolated thrombo-
cytopenia. No thrombocytopenic subject was found in the
control group. Among ten thrombocytopenic subjects in the
study group, one subject had a thrombocyte count of
<20,000/mm3 (10 %), one subject had a thrombocyte count
Table 2 Complete blood count
parameters in the subjects of the
study group and the control
group
The values in italics demonstrate
that p values less than <0.05 and
consider to be statistically
significant
a Values are given as mean±SD
(minimum–maximum)
Parameter Study group (n=31) Control group 2 (n=32) p
RBC (×106/mm3)a 4.4±0.3 (3.8–5.4) 4.1±0.4 (3.3–4.9) 0.02
Hb(g/dl)a 16.1±1.4 (14.4–19.3) 15.2±1.1 (12.9–17.7) 0.004
MCV (fl)a 111.1±5.3 (101–125) 107.8±7.8 (88–122) 0.11
MCH (pg)a 37.4±2 (34.9–42.2) 36.3±2.9 (29.5–40.7) 0.24
MCHC (g/dl)a 34±1.3 (30.9–37.6) 33.6±1.1 (31.5–35.6) 0.36
RDW (%)a 12.8±2.7 (9.8–18.6) 11±2 (9.7–17.2) 0.02
Reticulocyte (%)a 5.7±2.7 (3.6–15) 3.3±1.6 (1–8) <0.001
Normoblast (%)a 10.2±17.1 (2–78) 3.6±2.8 (0–12) 0.014
Leukocytes (×103/mm3)a 6.9±3.6 (1.6–14.6) 10.7±3.5 (3.7–17) <0.001
Neutrophils (×103/mm3)a 2.1±2 (0.2–9.6) 4.8±2.4 (1.3–10.4) <0.001
Lymphocytes (×103/mm3)a 3.4±1.9 (0.2–8.8) 4.2±1.9 (0.7–9.6) 0.04
Monocytes (×103/mm3)a 0.8±0.6 (0.1–2.1) 1.2±0.6 (0.3–2.7) 0.01
Eosinophils (×103/mm3)a 0.2±0.2 (0.01–0.9) 0.3±0.2 (0.01–0.8) 0.009
Basophils (×103/mm3)a 0.1±0.1 (0.09–0.5) 0.1±0.1 (0.04–0.4) 0.1
Thrombocytes (×103/mm3)a 168.2±81.7 (16–359) 256±602.4 (121–415) <0.001
MPV (fl)a 8.9±1.4 (7.4–13.4) 8.1±0.9 (6.8–10) 0.01
PDW (%)a 17.1±6.6 (8.1–33.8) 12.6±3 (8.5–21) 0.02
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of 20,000–50,000/mm3 (10 %) and eight subjects had a throm-
bocyte count of 50,000–150,000/mm3 (80 %). Conclusively,
25 of 31 subjects (80.6 %) in the study group and 8 of 32
subjects (25 %) in the control group were cytopenic. The
number of cytopenic subjects was found to be higher in the
study group compared to the controls (p<0.001).
When the subjects in the study group were evaluated in
terms of complete blood count parameters between them-
selves, no significant difference was found between hyper-
tensive groups (preeclampsia, chronic hypertension, and
transient hypertension induced by pregnancy) (p>0.05).
Prematurity and premature subjects
When prematurity was examined in cytopenic subjects, 15 of
18 neutropenic subjects, 8 of 11 lymphopenic subjects, 3 of 4
neutropenic+lymphopenic subjects and 9 of 10 thrombocy-
topenic subjects were premature in the study group. Both
neutropenic subjects and 5 of 6 lymphopenic subjects were
premature in the control group. While 20 of 25 cytopenic
subjects (80 %) were premature in the study group, 7 of
8 cytopenic subjects (87.5 %) were premature in the control
group.
When premature subjects were examined, the total number
of neutropenic subjects (15 vs. 2) (p<0.001), the number of
moderately neutropenic subjects (4 vs. 0) (p=0.05) and the
number of thrombocytopenic subjects (9 vs. 0) (p=0.004) was
found to be higher in the study group. No significant differ-
ence was found between the two groups in terms of the
number of mildly neutropenic subjects (6 vs. 2), the number
of lymphopenic subjects (8 vs. 5) and the number of
neutropenic+lymphopenic subjects (3 vs. 0) (p>0.05).
Cytopenia was present in 20 of 25 premature subjects
(80 %) in the study group and in 7 of 22 premature subjects
(31.8 %) in the control group. When the rates of cytopenia of
premature subjects were compared, the number of cytopenic
subjects was again found to be higher in the study group
compared to the controls (p=0.002). In the study group, birth
weight of neutropenic subjects was found to be lower com-
pared to non-neutropenic subjects (p=0.029). No significant
difference was found between the lymphopenic and throm-
bocytopenic subjects of the study group and the neutropenic
and lymphopenic subjects in the control group in terms of
birth weight (p>0.05).
Peripheral smear findings
Since fragmented neutrophils were found in the peripheral
smear of two subjects in group 2, these subjects were ex-
cluded from the evaluation performed in terms of neutro-
phils. Therefore, peripheral smear findings of the control
group were evaluated in 30 subjects in terms of neutrophils
and in 32 subjects in terms of erythrocytes and thrombocytes.
(a) Erythrocyte findings
Erythrocyte abnormalities (spherocytosis, anisocytosis,
poikilocytosis, and polychromasia) were found in 16
(51.6 %) of 31 subjects in the study group and in 7
(21.9 %) of 32 subjects in the control group. The difference
was found to be statistically significant (p=0.014).
(b) Leukocyte findings
There was no significant difference in terms of neutrophil
hypersegmentation (p>0.05). Mean number of lobes and
abnormality in the segmentation index were found with a
higher rate in the study group compared to the controls
(p<0.05). Nuclear structural defects were found in 96.7 %
of the study group and in 56.6 % of the control group. This
difference was considered to be significant (p<0.001). The
appearance of a defective nucleus was caused by nuclei with
hook, lump, and flag-like projections (Table 4).
Cytoplasmic granular defect was found in 61.3 % of the
study group and in 31.2 % of the control group. This difference
was significant (p=0.017). Similarly, membrane abnormality,
Table 3 Cytopenic subjects in the
study group and the control group
The values in italics demonstrate
that p values less than <0.05 and
consider to be statistically
significant
a Neutropenic+lymphopenic
subjects were also counted in the
neutropenic and lymphopenic
groups separately
b Since an isolated thrombocyto-
penic subject was not found,
thrombocytopenic subjects were





Single-variable logistic regression analysis
OR %95 CI p
Neutropenia (%) 18 (58.1) 2 (6.2) 20.7 4.196–102.796 <0.001
Mild neutropenia 8 (25.8) 2 (6.2) 5.2 1.010–26.949 0.034
Moderate neutropenia 6 (19.3) 0 (0) – – 0.009
Severe neutropenia 4 (12.9) 0 (0) – – 0.036
Lymphopenia (%) 11 (35.5) 6 (18.7) 2.3 0.752–7.549 0.13
Neutropenia+lymphopenia
(%)a
4 (12.9) 0 (0) – – <0.001
Thrombocytopenia (%)b 10 (32.2) 0 (0) – – <0.001
Total 25 (80.6) 8 (25) 12.5 3.774–41.400 0.001
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was found with a significantly higher rate in the study group
compared to the controls (35.5 % vs. 6.3 %, p=0.004). In the
evaluation of dysplastic findings performed by counting 100
neutrophils, defective nucleus (7.4±2.9 vs. 1.8±1.6), granular
distribution abnormality (2.7±4 vs. 0.9±1.3), and cytoplasmic
membrane protrusion (0.8±0.7 vs. 0.03±0.2) were found with
a higher rate in the study group (p<0.05). There was no
significant difference between the two groups in terms of
hypogranulation, which is one of the cytoplasmic defects
(0.06±0.2 vs. 0.09±0.4), agranulation (0.03±0.2 vs. 0), and
loss of integrity of cytoplasmic membrane (0.7±1.4 vs.
0.3±1.1) (p>0.05).
(c) Thrombocyte findings
Although the thrombocyte count was lower and MPV and
PDW values were found to be higher in the study group,
peripheral smears revealed giant thrombocytes only in three
subjects in the study group, the percent of giant thrombo-
cytes in these three subjects was 1 %, and thrombocyte
counts were <100,000/mm3. No difference was found be-
tween the two groups in terms of percentages of giant throm-
bocytes (0.1±0.3 vs. 0) and the number of subjects with giant
thrombocyte (3 vs. 0) (p=0.07). No difference was found
between hypertensive groups in terms of peripheral smear
findings when the subjects in the study group were evaluated
between themselves (p>0.05).
Vitamin B12, folate, ferritin
When serum vitamin B12, folate and ferritin levels were
compared between the two groups, no difference was found
(p>0.05) (Table 5).
Hemoglobin electrophoresis
When the two groups were compared in terms of hemoglobin
electrophoresis, Hb F levels were found to be significantly
higher and Hb A levels were found to be significantly lower
in the study group compared to the controls (p<0.001).
There was no significant difference between the two groups
in terms of HbA2 (p>0.05) (Table 5).
Follow-up of the subjects
When the subjects of both groups were evaluated in terms of
infections which occurred during a 1 year period, the number
of infections diagnosed by a physician was found to be
higher in the study group compared to the control group
(6.7±4.6 vs. 0.9±1.1, p<0.001) (Table 6). When the
infections were classified, the numbers of upper respira-
tory infections (4.7±3.4, vs. 0.7±1, p<0.001), urinary
infections (0.9±1.3 vs. 0.1±0.2, p<0.001), and acute
bronchiolitis (0.7±1.9 vs. 0.1±0.2, p=0.005) were found
to be higher in the study group compared to the control
group. There was no significant difference between the
two groups in terms of the number of gastroenteritis
(0.2±0.6 vs. 0.1±0.4, p=0.2).
Occurrence of more than eight upper respiratory infec-
tions in 1 year is defined as frequent infections. It was
observed that the number of frequent infections was higher
in the study group compared to the control group (9 vs. 0,
p<0.001). Six of nine subjects with frequent infections were
found to be neutropenic at birth (three mildly neutropenic,
two moderately neutropenic, and one severely neutropenic)
and three were found to be neutropenic+lymphopenic.
Peripheral smears revealed nuclear structure defects in all
Table 4 Comparison of periph-
eral smear findings of neutro-
phils in the study group and the
control group
The values in italics demonstrate
that p values less than <0.05 and
consider to be statistically
significant
a Values are given as mean±SD
(minimum–maximum)








The number of subjects with neutrophil
hypersegmentation (%)
2 (6.4) 0 (0) 0.1
Mean number of lobesa 2.32±0.2 (1.87–2.62) 2.03±0.2 (1.2–2.48) <0.001
Segmentation index abnormality (%)b 7 (22) 1 (3.3) 0.03
Nuclear structure defect (%) 30 (96.7) 17 (56.6) <0.001
Defective nucleus (in 100 neutrophils)a 7.4±2.9 (3–14) 1.8±1.6 (0–5) <0.001
Cytoplasmic findings
Cytoplasmic granule defect (%) 19 (61.3) 10 (33.3) 0.017
Hypogranulationa 0.06±0.2 (0–1) 0.09±0.4 (0–2) 1
Agranulationa 0.03±0.2 (0–1) 0 (0) 0.3
Granule distribution abnormalitya 2.7±4 (0–22) 0.9±1.3 (0–5) 0.02
Cytoplasmic membrane abnormality (%) 11 (35.5) 2 (6.6) 0.004
Membrane protrusiona 0.8±0.7 (0–2) 0.03±0.2(0–1) 0.006
Loss of integrity of membranea 0.7±1.4 (0–7) 0.3±1.1 (0–6) 0.06
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subjects, cytoplasmic granule defects in 6 subjects and mem-
brane abnormalities in four subjects.
Follow-up blood values were examined in 10 of 22
cytopenic subjects in the study group. All of these ten subjects
were neutropenic at the time of birth (seven neutropenic+
thrombocytopenic, three neutropenic+thrombocytopenic+
lymphopenic). Blood sampleswere taken at the age of 1month
from two of these subjects, at the age of 2 months from two
subjects, at the age of 10 months from one subject and at the
age of 1 year from five subjects. Cytopenia was not found in
any of the follow-up blood samples obtained from these
subjects.
Discussion
The frequency of preeclampsia in pregnant women ranges
between 10 and 14% in primigravid women and between 5.7
and 7.3 % in multigravid women [19]. It is mainly observed
during the first pregnancy of young mothers. In our study,
hypertensive mothers were found to be in the young popu-
lation and in their first pregnancies. Although there was no
significant difference between the two groups in terms of
mode of delivery, general anesthesia was performed with a
significantly higher rate in the study group compared to the
control group, when the procedure of anesthesia during
delivery was evaluated. This difference was thought to arise
from the fact that general anesthesia was performed at a
higher rate among subjects in the study group, who were
expected to have complications at a higher rate.
Early and long-term preeclampsia is reported to lead to a
decrease in nutrients nourishing the baby and to IUGR [1]. The
most commonly observed problem in the baby was growth
retardation. In pregnant women with chronic hypertension, the
rates of intrauterine growth retardation and fetal mortality are
rather high [18]. In our study, birth weights in the study group
were found to be significantly lower in the study group compared
to the control group. This finding suggested that hypertension in
pregnant women caused uteroplacental failure and this led to low
birth weight.
In the study performed by Kurlat et al., the risk of polycy-
themia was shown to be 12.6-fold higher in babies of hyper-
tensive mothers compared to the general population, and it
was proven that maternal hypertension constituted a signifi-
cant risk for polycythemia independent of fetal growth [12]. It
has been reported that normoblasts increase in babies of
preeclamptic mothers and this is secondary to uteroplacental
hypoperfusion [17]. In different studies, hemoglobin, MCV,
MCHC, RDW values, and reticulocyte counts were shown to
be higher in newborns of preeclamptic mothers [3, 7]. In our
study, the finding that erythrocyte counts, hemoglobin value,
reticulocyte percent and normoblast count were significantly
higher in babies of hypertensive mothers at the time of deliv-
ery can be explained by uteroplacental failure and increase in
Table 5 Vitamin B12, folate and ferritin levels and hemoblobin electrophoresis in the study group and the control group
Parameter Study group (n=31) Control group (n=32) p
Vitamin B12 (pg/ml) 420.5±255.1 (166.1–1058) 307.6±131.5 (122–653) 0.11
Folate (ng/ml) 17.7±3.3 (9.2–20) 17.7±3.2 (10.1–20) 0.89
Ferritin (ng/ml) 164.7±143.8 (23.7–848) 198.7±107.4 (102–635) 0.09
Hb A 28.2±7.9 (17–50.9) 36.8±6.9 (20–50.2) <0.001
Hb A2 0.14±0.54 (0–2.2) 0.10±0.44 (0–2.1) 0.14
Hb F 71.5±8.4 (48.5–82) 63.1±6.8 (49.8–80) <0.001
The values in italics demonstrate that p values less than <0.05 and consider to be statistically significant
Values are given as mean±SD (minimum–maximum)
Table 6 Comparison of the numbers of infections which occurred in the subjects in the study group and the control group during a 1-year follow-up
Parameters Group 1 (n=31) Group 2 (n=32) p
Total number of infections 6.7±4.6 (2–19) 0.9±1.1 (0–3) <0.001
Upper respiratory tract infection 4.7±3.4 (0–14) 0.7±1 (0–3) <0.001
Urinary infection 0.9±1.3 (0–5) 0.1±0.2 (0–1) <0.001
Acute bronchiolitis 0.7±1.9 (0–10) 0.1±0.2 (0–1) 0.005
Acute gastroenteritis 0.2±0.6 (0–2) 0.1±0.4 (0–2) 0.2
The values in italics demonstrate that p values less than <0.05 and consider to be statistically significant
Values are given as mean±SD (minimum–maximum)
Eur J Pediatr (2013) 172:1501–1509 1507
erythropoesis due to hypoxia. However, no significant differ-
ence was found between the two groups in terms of MCV,
MCH, and MCHC values.
Preeclampsia is known to be a risk factor for neonatal
neutropenia and thus for infections in premature newborns.
Koenig and Christensen suggested that neutropenia was
caused by a decrease in growth factors which increase neu-
trophil production, and decrease in response of progenitor
cells to growth factors and presence of inhibitor substance
inhibiting neutrophil production [10]. These investigators
showed that the activity of colony stimulating factor de-
creased in the placenta of hypertensive mothers and found
an inhibitor substance inhibiting neutrophil production in the
placenta. However, decrease in the response of progenitor
cells to growth factors could not be shown. In another study,
Fas–Fas ligand interaction was reported to be involved in
leucopenia in preeclampsia [11]. In another study, it was
reported that the balance of erythropoesis and granulopoesis
shifted to the direction of erythropoiesis, and because of
hypoxia and the resulting increase in reticulopoesis in
normal hematopoesis regulation, no adequate stem cells
remained for granulopoesis and as a result inadequate
granulopoesis was observed and dysgranulopoesis devel-
oped [13]. In our study, total counts of leukocytes, neu-
trophils, lymphocytes, monocytes, and eosinophils were
found to be significantly lower in the hypertensive group.
These findings are thought to be caused by one or more
of the aforementioned mechanisms.
In newborns of preeclamptic mothers, the incidence of
thrombocytopenia was shown to be higher compared to the
newborns of normotensive mothers [4, 16]. Although the
patophysiologic mechanism underlying thrombocytopenia
is not clear, there are studies reporting that it arises from
pathology at the placental level [14]. In these studies, it was
reported that thrombocytopenia could occur as a result of
thrombocyte adherence to the damaged endothelial region
caused by segmental vasospasma and vasodilatation in the
placenta of hypertensive mothers. Kleckner et al. reported
that abnormal placental endothelial surface caused thrombo-
cyte destruction and the resulting thrombocytopenia im-
proved in a short time after delivery [9]. It was also reported
that an undefined factor which leads to DIC was transported
to the baby by the placenta and caused thrombocytopenia in
the newborn [14]. In our study, thrombocyte counts and the
number of thrombocytopenic subjects were found to be
statistically lower in the hypertensive group. This finding
indicates that hypertensive pregnancy is a risk factor for
thrombocytopenia in the newborn. The finding that the num-
ber of cytopenic subjects was higher in the study group in our
study indicates that the newborns of hypertensive mothers
carry a higher risk in terms of cytopenia compared to other
newborns. The fact that there was no difference between
hypertensive groups in the study group in terms of complete
blood count parameters suggests that different hypertensive
diseases in pregnancy have similar effects in terms of caus-
ing cytopenia.
Increase in erythropoiesis, which develops because of
uteroplacental failure, and hypoxia can lead to abnormal
findings on peripheral smears, including spherocytosis,
anisocytosis, and polychromasia [5, 8]. In our study, the
aforementioned erythrocyte abnormalities were found on
peripheral smear examinations in 51.6 % of the study group
and 21.9 % of the control group. These findings support the
fact that displastic changes in newborns of hypertensive
mothers are observed at a higher rate.
Although platelet count was found to be low and MPV
and PDW values were found to be high in the study group,
no significant difference in peripheral smear examinations
between the two groups in terms of percentage of giant
thrombocytes suggests that the present thrombocytopenia is
caused by the moderate response of bone marrow. The fact
that no difference was found between the hypertensive sub-
groups in the study group in terms of peripheral smear
findings suggests that different hypertensive diseases of
pregnancy have similar effects in terms of causing develop-
ment of cellular dysplasia.
HbF has a higher affinity for oxygen compared to HbA.
The reason for this is the fact that HbF does not interact with
2,3-diphosphoglycerate at a significant level, and cells which
contain HbF display a higher oxygen affinity and have the
advantage of extracting more oxygen from maternal blood
by the placenta. There are studies which showed HbF levels
were increased in the umbilical cord in preeclampsia, which
is one of the diseases leading to uteroplacental failure, and
hypoxia, in addition to studies which showed that HbF levels
were increased also in maternal blood [15, 20]. In our study,
HbF levels were found to be significantly higher in the
hypertensive group compared to the control group and
HbA levels were found to be low. This finding was thought
to be caused by the stress developed in the fetus by
uteroplacental failure and hypoxia.
When the subjects in both groups were evaluated in terms
of infections during a 1-year period, it was observed that the
number of infections diagnosed by a physician was signifi-
cantly higher in the study group compared to the control
group. Most babies (72.2 %) who had more frequent infec-
tions were found to be neutropenic at birth. In these babies
lymphopenia was found at a lower rate (22.2 %). Nuclear
structure defects were found in all of them, cytoplasmic
granule defects were found in 66.6 % and membrane abnor-
malities were found in 38.8 %. This suggests that a positive
relation is present between frequent infections and neutrope-
nia, and nuclear and cytoplasmic dysplastic changes in neu-
trophils at birth.
In conclusion, birth weights were found to be lower in
newborns of hypertensive mothers because of uteroplacental
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failure and hypoxia compared to the control group and HbF
levels, and erythrocyte counts and Hb levels were found to be
higher. However, it was observed that neutropenia, thrombo-
cytopenia, and dysplastic changes in neutrophils, and erythro-
cytes on peripheral smears were found at a higher rate in
newborns of hypertensive mothers. Newborns of hypertensive
mothers carry a risk for complications including primarily
infection and bleeding. Therefore, hematologic follow-up
should be performed in these newborns. Complete blood
counts and peripheral smear examinations are significant
laboratory tests which can be used for early diagnosis
of hematologic complications in the newborn which
may be caused by hypertensive pregnancies.
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